FI20115165A0 - Terapeuttisia ja diagnostisia menetelmiä - Google Patents
Terapeuttisia ja diagnostisia menetelmiäInfo
- Publication number
- FI20115165A0 FI20115165A0 FI20115165A FI20115165A FI20115165A0 FI 20115165 A0 FI20115165 A0 FI 20115165A0 FI 20115165 A FI20115165 A FI 20115165A FI 20115165 A FI20115165 A FI 20115165A FI 20115165 A0 FI20115165 A0 FI 20115165A0
- Authority
- FI
- Finland
- Prior art keywords
- therapeutic
- diagnostic methods
- kit
- prevention
- treating
- Prior art date
Links
- 238000002405 diagnostic procedure Methods 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 201000007905 transthyretin amyloidosis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7047—Fibrils-Filaments-Plaque formation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20115165A FI20115165A0 (fi) | 2011-02-21 | 2011-02-21 | Terapeuttisia ja diagnostisia menetelmiä |
| CN201280019063.0A CN103492882B (zh) | 2011-02-21 | 2012-02-21 | 诊断甲状腺素运载蛋白淀粉状变性的方法及其试剂盒 |
| JP2013553968A JP2014510907A (ja) | 2011-02-21 | 2012-02-21 | 診断方法及び治療方法 |
| US14/000,683 US20150037341A1 (en) | 2011-02-21 | 2012-02-21 | Diagnostic and Therapeutic Method |
| EP12704819.7A EP2678689A1 (en) | 2011-02-21 | 2012-02-21 | Diagnostic and therapeutic methods |
| PCT/EP2012/052919 WO2012113784A1 (en) | 2011-02-21 | 2012-02-21 | Diagnostic and therapeutic methods |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20115165A FI20115165A0 (fi) | 2011-02-21 | 2011-02-21 | Terapeuttisia ja diagnostisia menetelmiä |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI20115165A0 true FI20115165A0 (fi) | 2011-02-21 |
Family
ID=43629837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI20115165A FI20115165A0 (fi) | 2011-02-21 | 2011-02-21 | Terapeuttisia ja diagnostisia menetelmiä |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20150037341A1 (fi) |
| EP (1) | EP2678689A1 (fi) |
| JP (1) | JP2014510907A (fi) |
| CN (1) | CN103492882B (fi) |
| FI (1) | FI20115165A0 (fi) |
| WO (1) | WO2012113784A1 (fi) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9879080B2 (en) | 2015-01-28 | 2018-01-30 | Prothena Biosciences Limited | Anti-transthyretin antibodies |
| US10464999B2 (en) | 2015-01-28 | 2019-11-05 | Prothena Biosciences Limited | Anti-transthyretin antibodies |
| TWI786505B (zh) * | 2015-01-28 | 2022-12-11 | 愛爾蘭商普羅佘納生物科技有限公司 | 抗甲狀腺素運送蛋白抗體 |
| US11028128B2 (en) | 2016-06-30 | 2021-06-08 | The Regents Of The University Of California | Inhibition of the aggregation of transthyretin by specific binding of peptides to aggregation-driving segments |
| MX2020003043A (es) | 2017-10-06 | 2020-10-05 | Prothena Biosciences Ltd | Métodos para detectar transtiretina. |
| MX2020003041A (es) * | 2017-10-06 | 2020-10-05 | Prothena Biosciences Ltd | Anticuerpos anti-transtiretina. |
| CN111433223B (zh) | 2017-11-29 | 2024-08-27 | 诺和诺德A/S(股份有限公司) | 抗甲状腺素运载蛋白单克隆抗体的冻干制剂 |
| CN116726148B (zh) * | 2023-08-02 | 2023-11-14 | 中国中医科学院针灸研究所 | 一种具有镇痛作用的化合物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5958883A (en) * | 1992-09-23 | 1999-09-28 | Board Of Regents Of The University Of Washington Office Of Technology | Animal models of human amyloidoses |
| EP2074223A4 (en) * | 2006-09-15 | 2010-03-10 | Foldrx Pharmaceuticals Inc | TEST PROCEDURE FOR THE DETECTION OF PROTEINS IN THE NATIVE CONDITION AND FOR THE IDENTIFICATION OF THE STABILITY OF PROTEINS IN THE NATIVE CONDITION MODULATING COMPOUNDS |
-
2011
- 2011-02-21 FI FI20115165A patent/FI20115165A0/fi not_active Application Discontinuation
-
2012
- 2012-02-21 JP JP2013553968A patent/JP2014510907A/ja active Pending
- 2012-02-21 WO PCT/EP2012/052919 patent/WO2012113784A1/en not_active Ceased
- 2012-02-21 EP EP12704819.7A patent/EP2678689A1/en not_active Withdrawn
- 2012-02-21 US US14/000,683 patent/US20150037341A1/en not_active Abandoned
- 2012-02-21 CN CN201280019063.0A patent/CN103492882B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20150037341A1 (en) | 2015-02-05 |
| CN103492882A (zh) | 2014-01-01 |
| WO2012113784A1 (en) | 2012-08-30 |
| CN103492882B (zh) | 2016-06-22 |
| JP2014510907A (ja) | 2014-05-01 |
| EP2678689A1 (en) | 2014-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124307T1 (el) | Φαρμακευτικη συνθεση, μεθοδοι θεραπειας και χρησεις αυτων | |
| BR112014021104A2 (pt) | métodos e composições para o tratamento da doença de huntington | |
| AU2011328009A8 (en) | Compounds and methods for treating pain | |
| MX343135B (es) | Compuestos de tipo fumagilol y métodos de realización y uso de los mismos. | |
| BR112014010299A2 (pt) | composição para prevenir e tratar doenças da cavidade oral; método de prevenção e tratamento de doenças da cavidade oral; e uso da composição | |
| EA201290919A1 (ru) | Индазольные соединения и их применение | |
| MY169328A (en) | Compositions for the treatment of dry eye | |
| EA201490748A1 (ru) | Лечение рассеянного склероза комбинацией лахинимода и финголимода | |
| FI20115165A0 (fi) | Terapeuttisia ja diagnostisia menetelmiä | |
| EP2726511A4 (en) | COMPOSITIONS, USES AND METHODS FOR THE TREATMENT OF METABOLIC DISORDERS AND DISEASES | |
| MX382162B (es) | Combinaciones farmacéuticas de un inhibidor de enzima hdac con un inhibidor de proteasoma, y su uso en el tratamiento de cáncer. | |
| UA117096C2 (uk) | Поліпептид, що зв'язується з c5 комплементу людини | |
| EA201690039A1 (ru) | Ингибиторы rorc2 и способы их применения | |
| MX356755B (es) | Compuestos de tipo fumagilol y metodos para su elaboración y uso. | |
| EA201491500A1 (ru) | Способы лечения фиброза | |
| TW201613578A (en) | Pharmaceutical combinations | |
| CY1120877T1 (el) | Συνθεσεις και μεθοδοι για την αντιμετωπιση της κοιλιοκακης | |
| UA114417C2 (uk) | Інгібітори iap | |
| PH12016502352A1 (en) | Pharmaceutical composition | |
| EP4272839A3 (en) | Treatment of allergic rhinitis using a combination of mometasone and olopatadine | |
| BR112013010136A2 (pt) | vacina, composição terapêutica e métodos para o tratamento ou inibição de gliblastoma | |
| EA201591507A1 (ru) | Лечение рассеянного склероза лахинимодом | |
| BR112013017184A2 (pt) | composto, composição farmacêutica, uso de um composto, e, método para evitar, tratar ou melhorar doenças | |
| EP2563120A4 (en) | METHOD, COMPOSITIONS AND KITS FOR PROVIDING THERAPEUTIC TREATMENT | |
| EA201491581A1 (ru) | Везикулярные композиции |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |